SavedAdd your journal

Journals / Infectious diseases and clinical microbiology (Online) / 2020 / Cilt: 2 - Sayı: 1

Typical Evolution of a CutaneousAnthrax Lesion

Cansu ÇİMEN
Pages
27–29
Publication Date
2022-10-19
DOI
—
🏛️Bibliographic metadata and full text access for this article are provided via DergiPark.
DergiPark Record ↗
✨

AI Summary & Key Takeaways

AI Insight
⚡ TL;DR(Too Long; Didn't Read)

This case report was presented in order to help clinicians to recognize the different stages of the disease in clinical practice.

📌 3 Key Takeaways

🎯
Objective & Hypothesis:An illustrated case of cutaneous anthrax acquired in eastern Turkey was described in this report.
📊
Key Findings & Data:A 56-year-old female patient applied to the infectious diseases outpatient clinic with a painless, dark-colored swelling over her right middle finger accompanied by edema extending to the right hand.
💡
Conclusion & Impact:This case report was presented in order to help clinicians to recognize the different stages of the disease in clinical practice.
🔬Design:Research Article
📍Scope:Comprehensive Sample
⚙️Variables:Domain Parameters

Abstract

An illustrated case of cutaneous anthrax acquired in eastern Turkey was described in this report. A 56-year-old female patient applied to the infectious diseases outpatient clinic with a painless, dark-colored swelling over her right middle finger accompanied by edema extending to the right hand. Typical disease course of a cutaneous anthrax lesion evolved in a few days. This case report was presented in order to help clinicians to recognize the different stages of the disease in clinical practice.

🔖

Cite This Article

ÇİMEN, C. (2022). Typical Evolution of a CutaneousAnthrax Lesion. Infectious diseases and clinical microbiology (Online), Cilt: 2 - Sayı: 1, 27–29. https://ajindex.com/articles/539109

📄 Full Text PDF Viewer

📄

PDF görüntüleyici hazırlanıyor...

References (1)

  1. 1 Anthrax in Humans and Animals. 4th ed. Turnbull P, editor. Geneva: World Health Organisation; 2008. 2 Dixon TC, Meselson M, Guillemin J, Hanna PC. Anthrax. N Engl. J. Med 1999; 341: 815–826. 3 Hendricks KA, Wright ME, Shadomy SV, Bradley JS, Morrow MG, Pavia AT, et al. Centers for Disease Control and Prevention expert panel meetings on prevention and treatment of anthrax in adults. Emerg Infect Dis 2014; 20: e130687. 4 Shadom SV, Smith TL. Zoonosis update. Anthrax. J Am Vet Med Assoc 2008; 233: 63-72. 5 Doganay M, Metan G, Alp E. A review of cutaneous anthrax and its outcome. J Infect Public Health 2010; 3: 98-105. 6 Kamal SM, Rashid AK, Bakar MA, Ahad MA. Anthrax: An update. Asian Pac J Trop Biomed 2011; 1: 496–501. 7 Kaya A, Tasyaran MA, Erol S, Ozkurt Z, Ozkan B. Anthrax in adults and children: A review of 132 cases in Turkey. Eur J Clin Microbiol. Infect. Dis 2002; 21: 258–261. 8 Abdenour D, Larouze B, Dalichaouche M, Aouati M. Familial Occurrence of Anthrax in Eastern Algeria. J Infect Dis 1987; 155: 1083–4. 9 Parlak E, Parlak M. Human Cutaneous Anthrax, the East Anatolian Region of Turkey 2008-2014. Vector-Borne Zoonotic Dis 2016; 16: 42–7. 10 Wenner KA, Kenner JR. Anthrax. Dermatol Clin 2004; 22: 247– 256. 11 Baykam N, Ergonul O, Ulu A, Eren S, Celikbas A, Eroglu M, et al. Characteristics of cutaneous anthrax in Turkey. J Infect Dev Ctries 2009; 3: 599–603.